Peter Maclean Hoagland, M.D.
NPI 1629059779ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· San Diego, CA
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) in San Diego, California, licensed in CA, with an NPI issued in November 2005. Their prescriptions cost Medicare Part D more than their services did: $1,229,272 for 5,043 claims, against $483,714 paid for services in 2024. Novartis Pharmaceuticals Corporation was the largest of 9 companies reporting payments in 2025, $332.52 in all, mostly food and beverage.
Overview
| NPI | 1629059779 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Nov 7, 2005 |
| Last updated in NPPES | Mar 23, 2023 |
| Certified by provider | Mar 23, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | G54598 | CA |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | G54598 | CA |
| Nuclear Medicine, Nuclear Cardiology | 207UN0901X | G54598 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 733 |
|---|---|
| Services billed | 3,817 across 48 procedure codes |
| Paid by Medicare | $483,714 |
Part D prescriptions in 2024
| Prescriptions (claims) | 5,043 · 13,480 30-day fills |
|---|---|
| Patients | 548 |
| Total drug cost | $1,229,272 |
| Generic share | 82% of claims |
Industry payments (Open Payments)
- 2025$332.52 · 14 payments from 9 companies
- 2024$434.11 · 20 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $70.20 | 4 |
| Heartflow, Inc. | $64.01 | 1 |
| Merck Sharp & Dohme LLC | $61.57 | 2 |
| Alnylam Pharmaceuticals Inc. | $38.38 | 2 |
| Actelion Pharmaceuticals US, Inc. | $24.66 | 1 |
What the 2025 payments were for
- Food and Beverage$332.52 · 14 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in San Diego
- 1912754581
- 1477699601
- 1669497731
- 1073161329
- 1457770240
- 1548657075
- 1093773137
- 1194706242
- 1417104837
- 1407099799
- 1831393289
- 1023438637
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in California →